Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 5.55 |
| Open | 5.63 |
| Bid | 5.56 x 3100 |
| Ask | 5.98 x 800 |
| Day's Range | 5.55 - 5.80 |
| 52 Week Range | 2.50 - 9.49 |
| Volume | |
| Avg. Volume | 894,883 |
| Market Cap | 700.207M |
| Beta (5Y Monthly) | 2.68 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.12 |
| Earnings Date | May 02, 2023 - May 08, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.29 |
- Zacks
Seres Therapeutics (MCRB) Moves 10.9% Higher: Will This Strength Last?
Seres Therapeutics (MCRB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Business Wire
Seres Therapeutics to Participate in Oppenheimer 33rd Annual Healthcare Conference
CAMBRIDGE, Mass., March 09, 2023--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, will provide a corporate presentation at the Oppenheimer 33rd Annual Healthcare Conference on Wednesday, March 15, 2023 at 8:40 a.m. ET.
- Thomson Reuters StreetEvents
Q4 2022 Seres Therapeutics Inc Earnings Call
Q4 2022 Seres Therapeutics Inc Earnings Call
© 2023 Yahoo. All rights reserved.
